CRHM Stock: 14 Things to Know About CRH Medical as Well Health Deal Catapults Shares

CRH Medical (NYSEAMERICAN:CRHM) stock is on the rise Monday after announcing a deal with Well Health.

Image of a hospital with workers walking in the halls

Source: Shutterstock

Here’s everything investors need to know about CRHM stock and the company.

  • The deal announced today has Well Health spending $292.7 million to acquire all outstanding shares of CRHM stock.
  • This has it offering up $4 for each share of CRHM stock.
  • That’s an 83% premium over the stock’s closing price on Friday.
  • It’s also an 80% premium to CRHM stock’s 30-day volume-weighted average price.
  • The total value of the deal comes to $369.2 million when including the credit facility.
  • Well Health has commitments to financing that will allow it to fund the purchase of CRH Medical.
  • Now, the deal needs approval from shareholders of CRHM stock before it can close.
  • So long as there are no issues, the two companies expect the acquisition deal to reach completion in the second quarter of 2021.
  • CRH Medical is a U.S. company focused on providing products and services to gastroenterologists to treat gastrointestinal diseases.
  • This has it providing “provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers.”
  • The company currently serves 69 ambulatory surgical centers across 13 states.
  • It also owns the CRH O’Regan System, which treats all grades of hemorrhoids.
  • CRH Medical was founded in 2000 and joined the public market in 2006.
  • Its headquarters is located in Vancouver, Canada.

CRHM stock was up 24.9% as of Monday morning.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article.


Article printed from InvestorPlace Media, https://investorplace.com/2021/02/crhm-stock-14-things-to-know-about-crh-medical-as-well-health-deal-catapults-shares/.

©2021 InvestorPlace Media, LLC